Cargando…
ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide, and the 5-year survival rates are among the worst of the major cancers. Oncolytic herpes simplex viruses (oHSV) have the potential to make a significant impact in the targeted treatment of these patients. Here...
Autores principales: | Yoo, Ji Young, Yu, Jun-Ge, Kaka, Azeem, Pan, Quintin, Kumar, Pawan, Kumar, Bhavna, Zhang, Jianying, Mazar, Andrew, Teknos, Theodoros N, Kaur, Balveen, Old, Matthew O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782961/ https://www.ncbi.nlm.nih.gov/pubmed/27119105 http://dx.doi.org/10.1038/mto.2015.8 |
Ejemplares similares
-
The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016) -
The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma
por: LEE, KRISTY, et al.
Publicado: (2014) -
Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Jaime-Ramirez, Alena C., et al.
Publicado: (2017) -
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
por: Doñate, F, et al.
Publicado: (2008) -
Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis
por: Yadav, Arti, et al.
Publicado: (2015)